Recent insider trading activity from Deck Kelly, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2025 | Inhibrx Biosciences, Inc. | $INBX | Deck Kelly | Chief Financial Officer | A | Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 14,476,000 | 9999.99% | 0.10% |
| May 30, 2024 | Inhibrx Biosciences, Inc. | $INBX | Deck Kelly | Chief Financial Officer | A | Stock Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 14,475,904 | 9999.99% | 1.21% |